ARCHIVES

Novartis Begins Study Of Femara And Zometa In Postmenopausal Early Breast Cancer

This article is from The Cancer Letter archive.

Vol. 25 No. 12 | December 27, 2002

Download PDF Visit The Full Archive

Related Articles

MAP Says It Will Continue Operating With Private Funds

April 18, 1986

Cancer Policy: NCAB Chairmen sent Letter To Senator Defending NCI director

April 11, 1997

Fellowships In Japan Available Through NIH

October 13, 1995

Majority Of Physicians Support Clinical Alert, But some NCAB Members Still Not Convinced

November 18, 1988

In Brief: Henney Permanent NCI Deputy Director; 17 Regional Cooperative Group Applications Get First Review

February 5, 1982

Cancer Advocacy: March On Washington Scheduled For September 1998

October 31, 1997